Lineage Cell Therapeutics's top three insider shareholders as of March 23, 2026 are Partners, L.P. Broadwood (Director, 49.56Mn shares), Alfred D Kingsley (Director, 5.47Mn shares), Michael H. Mulroy (Director, 298.56K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners, L.P. Broadwood | 49,560,992 | 0 | 28 Jan, 2025 | |
| Alfred D Kingsley | 5,470,245 | 0 | 23 Jun, 2021 | |
| Michael H. Mulroy | 298,555 | 0 | 25 Nov, 2024 | |
| Brian M Culley | President And Ceo | 255,516 | 0 | 12 Mar, 2026 |
| Brian M Culley | President And Ceo | 240,516 | 0 | 13 Feb, 2026 |
| Don M Bailey | 0 | 158,801 | 08 Feb, 2024 | |
| Neal C Bradsher | 87,628 | 0 | 25 Jun, 2021 | |
| Angus C. Russell | 87,500 | 0 | 30 Jun, 2021 | |
| Dipti Amin | 35,000 | 0 | 29 Mar, 2022 | |
| George A. Iii Samuel | General Counsel And Secretary | 31,063 | 0 | 13 Feb, 2026 |
| Jill Ann Howe | Chief Financial Officer | 25,500 | 0 | 26 Nov, 2024 |
| Deborah J Andrews | 15,578 | 0 | 30 Jun, 2021 | |
| Deborah J Andrews | 15,578 | 0 | 30 Jun, 2021 | |
| Anula Jayasuriya | 10,000 | 0 | 02 Jan, 2024 | |
| Gary S. Hogge | Svp,Clinical Medical Affairs | 7,710 | 0 | 14 Feb, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Brian M Culley | Common Shares | A | 15,000 | $1.63 | 255,516 | D | P |
| 05 Mar, 2026 | Brian M Culley | Employee Stock Option (Right to Buy) | A | 3,250,000 | $0.00 | 3,250,000 | D | A |
| 05 Mar, 2026 | Brian M Culley | Employee Stock Option (Right to Buy) | A | 3,250,000 | $0.00 | 3,250,000 | D | A |
| 05 Mar, 2026 | George A. Iii Samuel | Employee Stock Option (Right to Buy) | A | 900,000 | $0.00 | 900,000 | D | A |
| 05 Mar, 2026 | Jill Ann Howe | Employee Stock Option (Right to Buy) | A | 1,050,000 | $0.00 | 1,050,000 | D | A |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | A | 6,075 | - | 33,565 | D | M |
| 11 Feb, 2026 | Brian M Culley | Common Shares | A | 31,250 | - | 253,385 | D | M |
| 11 Feb, 2026 | Brian M Culley | Common Shares | A | 31,250 | - | 253,385 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Common Shares | D | 2,502 | $1.80 | 31,063 | D | F |
| 11 Feb, 2026 | Brian M Culley | Common Shares | D | 12,869 | $1.80 | 240,516 | D | F |
| 11 Feb, 2026 | Brian M Culley | Common Shares | D | 12,869 | $1.80 | 240,516 | D | F |
| 11 Feb, 2026 | Brian M Culley | Restricted Stock Units | D | 31,250 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | George A. Iii Samuel | Restricted Stock Units | D | 6,075 | $0.00 | 0 | D | M |
| 11 Feb, 2026 | Brian M Culley | Restricted Stock Units | D | 31,250 | $0.00 | 0 | D | M |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | A | 1,735 | - | 27,555 | D | A |
| 19 Dec, 2025 | Brian M Culley | Common Shares | A | 8,925 | - | 222,469 | D | A |
| 19 Dec, 2025 | Brian M Culley | Common Shares | A | 8,925 | - | 222,469 | D | A |
| 19 Dec, 2025 | Brian M Culley | Common Shares | D | 334 | $1.68 | 222,135 | D | F |
| 19 Dec, 2025 | George A. Iii Samuel | Common Shares | D | 65 | $1.68 | 27,490 | D | F |
| 19 Dec, 2025 | Brian M Culley | Common Shares | D | 334 | $1.68 | 222,135 | D | F |